NDC 72526-104 Rykindo Extended-release Microspheres
Risperidone Kit - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
Code Structure Chart
Product Details
What is NDC 72526-104?
What are the uses for Rykindo Extended-release Microspheres?
Which are Rykindo Extended-release Microspheres UNII Codes?
The UNII codes for the active ingredients in this product are:
- RISPERIDONE (UNII: L6UH7ZF8HC)
- RISPERIDONE (UNII: L6UH7ZF8HC) (Active Moiety)
Which are Rykindo Extended-release Microspheres Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- POLY(DL-LACTIC-CO-GLYCOLIC ACID), (75:25; 140000 MW) (UNII: 1SIA8062RS)
- POLY(DL-LACTIC-CO-GLYCOLIC ACID), (50:50; 46000 MW) (UNII: LQ35R50VR1)
- MANNITOL (UNII: 3OWL53L36A)
- CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)
- SODIUM PHOSPHATE, DIBASIC, ANHYDROUS (UNII: 22ADO53M6F)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- SODIUM HYDROXIDE (UNII: 55X04QC32I)
- WATER (UNII: 059QF0KO0R)
What is the NDC to RxNorm Crosswalk for Rykindo Extended-release Microspheres?
- RxCUI: 2639732 - Rykindo 12.5 MG Extended Release Injection
- RxCUI: 2639732 - risperidone 12.5 MG Injection [Rykindo]
- RxCUI: 2639732 - Rykindo 12.5 MG Injection
- RxCUI: 2639734 - Rykindo 25 MG Extended Release Injection
- RxCUI: 2639734 - risperidone 25 MG Injection [Rykindo]
* Please review the disclaimer below.
Patient Education
Risperidone Injection
Risperidone extended-release injection (Perseris, Risperdal Consta, Rykindo, Uzedy) is used to treat schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions). Risperidone extended-release injection (Risperdal Consta, Rykindo) is used alone or in combination with lithium (Lithobid) or valproate to treat people who have bipolar I disorder (manic depressive disorder; a disease that causes episodes of depression, episodes of severe mania, and other abnormal moods). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".